Table III.
Comparison of PLR, NLR, dNLR and LMR values between patients who survived and died during follow-up
Parameter | Survivors N = 264 | Cancer-specific deaths N = 91 | Cancer-unrelated deaths N = 88 | P-value (all groups) | P-value (survivors vs. cancer-specific deaths) | P-value (survivors vs. cancer-unrelated deaths) | P-value (cancer-specific deaths vs. cancer-unrelated deaths) |
---|---|---|---|---|---|---|---|
PLR | 117.8 (90.9–147.1) | 176.3 (117.0–233.1) | 138.3 (96.1–186.9) | < 0.0001 | < 0.0001 | 0.003 | 0.02 |
NLR | 1.82 (1.39–2.36) | 2.92 (2.18–4.09) | 2.23 (1.6–3.31) | < 0.0001 | < 0.0001 | 0.002 | 0.0004 |
dNLR | 1.33 (1.0–1.7) | 1.77 (1.45–2.45) | 1.61 (1.21–2.24) | < 0.0001 | < 0.0001 | 0.003 | 0.07 |
LMR | 4.8 (3.76–6.0) | 3.07 (2.12–4.25) | 3.76 (2.63–5.75) | < 0.0001 | < 0.0001 | 0.0004 | 0.02 |
Continuous variables are presented as median (interquartile range). PLR – platelet-lymphocyte ratio, NLR – neutrophil-lymphocyte ratio, dNLR – derived neutrophil-lymphocyte ratio, LMR – lymphocyte-monocyte ratio.